Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

The first of 20 new replacement chalets arrived at Double Dykes permanent Gypsy/Traveller site this week, a significant ...

We expect Boss Zhipin to continue its growth in both monthly active users, or MAU, and paying enterprise customers in the near term, but there could be challenges in reaching its target. Kanzhun ...

On 5 March 2025, the FCA published its findings from its multi-firm assessment of governance and valuation practices within the private market ...

This year marks the 100th year since the University of Iowa Iowa Memorial Union was constructed. In 2008, the building ...

REHOVOT, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: ...

River Road in Louisville will start going through phased closures as it undergoes a major infrastructure improvement project.

Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...

Ethereum has successfully deployed the Pectra upgrade on the Sepolia Testnet, promising major innovations for the Ethereum ...

In today's fast-paced business environment, efficiency is paramount. Yet, even the most well-oiled machines can encounter ...